Locations
Mississauga, ON, Canada · London, ON, Canada
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2017
Epineuron is a clinical-stage nerve care company developing a novel class of bioelectronic therapy that offers a transformative approach to aid in the treatment of injured peripheral nerves. Their flagship product, the Peri Pulse™, is a temporary wearable system designed to deliver proprietary bioelectronic therapy for nerve regeneration, which has received Health Canada approval and is designated as an FDA Breakthrough device. The company aims to integrate this innovative therapy into standard surgical workflows, enhancing nerve recovery without disrupting procedures. With a strong intellectual property portfolio and a team of experienced leaders, Epineuron is positioned to revolutionize nerve recovery and establish itself as a leader in bioelectronic medicine.
Something looks off?